N/A
N=37
Two Daily Disposable Contact Lenses in Symptomatic Patients
Myopia
Bottom Line
View on ClinicalTrials.gov: NCT03628599 ↗Enrolled (actual)
37
Serious AEs
0.0%
Results posted
Jul 2019
Primary outcome: Primary: Monocular Corrected Distance Visual Acuity (VA) — -0.01; -0.02 logMAR
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Delefilcon A contact lenses (Device); Senofilcon A contact lenses (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Alcon Research
- Primary completion
- Sep 2018
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Monocular Corrected Distance Visual Acuity (VA) |
-0.01; -0.02 | — |
Summary
The purpose of this study is to evaluate the performance of DAILIES TOTAL1® and ACUVUE OASYS® 1-DAY and with respect to visual acuity in a symptomatic study population of monthly or bi-weekly replacement lens wearers.
Eligibility Criteria
Inclusion Criteria
- Able to understand and must sign an IRB-approved informed consent form;
- Soft contact lens wearers in both eyes during the past 3 months;
- Best-corrected visual acuity (BCVA) 20/25 or better in each eye;
- Willing to wear study lenses at least 3 days per week and at least 8 hours per day;
- Willing to stop wearing habitual contact lenses for the duration of study participation.
Exclusion Criteria
- Infection, inflammation, abnormality, condition, disease, surgery, or use of medications, as specified in the protocol;
- Intolerance, hypersensitivity, or allergy to any component of the study products;
- Wearing habitual contact lenses in an extended wear modality (routinely sleeping in lenses for at least 1 night per week) over the last 3 months prior to enrollment;
- Monocular (only one eye with functional vision).
Data sourced from ClinicalTrials.gov (NCT03628599). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.